Aptatek Biosciences Funding & Investors

Aptatek develops the diagnosis and monitoring of inborn diseases in centralized laboratories. Aptatek’s core technology is based on DNA aptamer sequences that detect small-molecule biomarkers and blood pressure. They can identify a large range of markers that are now only analyzed in a laboratory.